助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   hepatitis and liver cirrhosis 的翻译结果: 查询用时:0.227秒
图标索引 在分类学科中查询
所有学科
消化系统疾病
感染性疾病及传染病
更多类别查询

图标索引 历史查询
 

hepatitis and liver cirrhosis
相关语句
  肝炎和肝硬化
     The protein levels of CyclinD1,CDK4 and p16 were higher in paratumor cirrhosis and HCC than those in chronic hepatitis and liver cirrhosis, P=0.034,0.020,0.030,0.007,0.003 and 0.005, whereas there was no significant difference between the expressions in paratumor cirrhosis and in HCC.
     癌周肝硬化和肝癌组织中cyclinD1、CDK4、p16的表达明显高于慢性肝炎和肝硬化(P值分别为0.034、0.020、0.030、0.007、0.003和0.005),但癌周肝硬化和肝癌组织之间差异无统计学意义,P值分别为0.433、0.535和0.447。
短句来源
     In patients with acute hepatitis, severe hepatitis, and liver cirrhosis, the expression of positive HDAg and negative HBeAg was obviously higher than that of positive HDAg and HBeAg (P < 0.01 or P < 0.05).
     急性肝炎、重型肝炎和肝硬化HDAg(+)、HBeAg(-)表达高于HDAg、HBeAg均阳性者(P<0.01或P<0.05)。
短句来源
     CyclinD1 and CDK4 protein levels were noted to be higher in paratumor cirrhosis and HCC than in chronic hepatitis and liver cirrhosis (P<0.05), whereas there was no significant difference between the expressions in paratumor cirrhosis and in HCC (P>0.05).
     癌周肝硬化和肝癌中cyclinD1、CDK4的表达明显高于慢性肝炎和肝硬化(P<0.05),但癌周肝硬化和肝癌之间差异无显著性(P>0.05)。
短句来源
     Clinical Observation of Effect of Astragale Injection on Albumin Level in Patients with Chronic Hepatitis and liver Cirrhosis
     黄芪注射液对慢性肝炎和肝硬化患者白蛋白作用的临床观察
短句来源
     But in acute hepatitis,severe hepatitis and liver cirrhosis,the expression of HDAg(+)/HBeAg(-)were obviously higher than that of HDAg(+)/HBeAg(+).
     在急性肝炎、重型肝炎和肝硬化患者HDAg( +)HBeAg( -)为主要血清病毒表现形式 (P <0 .0 1或 0 .0 5 )。
短句来源
更多       
  肝炎及肝硬化
     Expression of Serum MMP-13,TNF-α and IL-6 in Patients with Chronic Hepatitis and Liver Cirrhosis
     慢性肝炎及肝硬化患者血清中MMP-13、TNF-α及IL-6的表达
短句来源
     Objective:To investigate the variation of serum transforming growth factor β 1 (TGF β 1) in patients with acute hepatitis,chronic hepatitis and liver cirrhosis and the role of TGF β 1 in the pathophysiologic process of liver fibrosis and cirrhosis.
     目的 :了解急、慢性肝炎及肝硬化患者血清转化生长因子 β1(transforminggrowthfactorβ1,TGFβ1)水平的变化 ,探讨TGFβ1在肝纤维化、肝硬化发病中的作用。
短句来源
     Results Serum concentrations of HA,ⅣC and LN were remarkably increased with the progression of the disease,and reached the highest levels in chronic severe hepatitis and liver cirrhosis(P<0 01).
     结果 血清HA、ⅣC、LN水平与慢性肝炎发展呈正相关 ,且在慢性重度肝炎及肝硬化阶段处于最高水平 (P <0 0 1)。
短句来源
     Conclusions:We suggested there was no change of the serum TGF β 1 in patients with acute hepatitis,the serum TGF β 1 were significantly higher in chronic hepatitis and liver cirrhosis and those were higher in the patients with liver cirrhosis than those in chronic hepatitis.
     结论 :慢性肝炎及肝硬化患者TGFβ1分泌增加 ,且肝硬化比慢性肝炎患者增加更明显 ; 而急性肝炎患者TGFβ1分泌无明显变化。
短句来源
     Changes of Serum Fatty Acid in Chronic Hepatitis and Liver Cirrhosis
     慢性肝炎及肝硬化患者血清脂肪酸组分变化
短句来源
更多       
  肝炎和肝硬变
     The density of the apoptotic cells in severe viral hepatitis was significantly higher than that in chronic hepatitis and liver cirrhosis (both P<0. 01).
     比较各型肝炎的凋亡细胞密度发现,重型肝炎的凋亡细胞密度高于慢性肝炎和肝硬变(P均<0.01);
短句来源
     Relationship between Proliferation of Intrahepatic Elastic Fiber and Hepatitis and Liver Cirrhosis
     肝内弹力纤维增生与肝炎和肝硬变的关系
短句来源
  “hepatitis and liver cirrhosis”译为未确定词的双语例句
     Results The parameter of the group severity chronic hepatitis and liver cirrhosis were different to the group control with RBC, RDW (P<0.05), PLT (P<0.01);
     结果慢性肝炎重度RBC、RDW(P<0.05)、PLT(P<0.01),与对照组比较有显著性差异;
短句来源
     Results PI was gradually increased from healthy volunteers to patients with chronic hepatitis and liver cirrhosis (1.01±0.04, 1.06±0.09, and 1.18±0.09), and the differences in PI value among them were significant (F=22.294, P<0.01).
     结果PI值在正常对照组、慢性肝炎组和肝硬化组中逐渐增高,分别为1.01±0.04、1.06±0.09、1.18±0.09,各组间差异有统计学意义(F=22.294,P<0.01)。
短句来源
     The time from PT>120 s to patient death was 1-10 days,mean 2.5±2.2 days,for which acute severe hepatitis and liver cirrhosis were 1-2 days,chronic severe hepatitis was 1-10 days.
     患者从PT>120 s到死亡(无效)的时间为1~10 d,平均2.5±2.2 d,其中急性重型肝炎和亚急性重型肝炎以及肝硬化失代偿均在1~2 d内死亡或者放弃治疗;
短句来源
     ResultsMutation and wild strain infections in 229 patients with HBV infection were detected using this msPCR method. The rate of nt1896 mutation infection in patients with acute hepatitis, light, moderate, severe chronic hepatitis and liver cirrhosis was (25.0%), (5.3%), (5.2%), (27.8%) and 20.0%, respectively.
     结果229例急性肝炎、慢性肝炎轻度、中度、重度及肝硬化患者nt1896突变株感染率分别为25.0%、5.3%、5.2%、27.8%和20.0%;
短句来源
     The RR of hepatitis and liver cirrhosis developing to hepatoma were 26.78 and 2.27 respectively.
     肝硬化和病毒性肝炎患者发生肝癌的相对危险度分别为26.78和2.27。
短句来源
更多       
查询“hepatitis and liver cirrhosis”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  hepatitis and liver cirrhosis
Hepatitis B viral (HBV) infection in early childhood is one of the leading causes of chronic hepatitis and liver cirrhosis that eventually lead to hepatic carcinoma.
      
On autonomic nervous lesions in viral hepatitis and liver cirrhosis
      
There was no difference inserum sIL-2R levels between asymptomatic HBV carriersand healthy controls or between patients with chronic hepatitis and liver cirrhosis.
      
Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy
      
Osteodystrophy in patients with chronic hepatitis and liver cirrhosis
      
更多          


Dan-shen (Radix Salviae Miltiorrhizae) and Chuipen-cao (Sedum sarmentosum Bunge.) have been reported to be effective in treating chronic hep-atitis. A compositus preparation of these 2 plants "Dan-Chui granules", readily soluble in hot water, was given orally 20g tid(maintenance dose 10-20 g bid) to 60 patients with chronic hepatitis and liver cirrhosis for 4-6 months.After 8wk of medication,the SGPT level reached normal in 82% of the cases and the total effective rate was 90% of the patients with high...

Dan-shen (Radix Salviae Miltiorrhizae) and Chuipen-cao (Sedum sarmentosum Bunge.) have been reported to be effective in treating chronic hep-atitis. A compositus preparation of these 2 plants "Dan-Chui granules", readily soluble in hot water, was given orally 20g tid(maintenance dose 10-20 g bid) to 60 patients with chronic hepatitis and liver cirrhosis for 4-6 months.After 8wk of medication,the SGPT level reached normal in 82% of the cases and the total effective rate was 90% of the patients with high SGPT sustained for 3-12 months; serum bilirubin was normalized in 96% of the patients with jaundice for more than 3 months. Adverse drug reactions were not seen. The recurrence rate, 6 months after thecessation of medication, was 29%in contrast to 80% in 110 patients treated with current hepato-protective drugs.To conclude, it is a good remedy for treatment of hepatitis.

本文介绍了上海地区近10yr对景天科垂盆草的研究进展,报告了第三代垂盆草制剂——复方丹垂冲剂治疗60例血清转氨酶持续异常3-12mo以上的慢性肝炎及肝硬化患者的临床疗效。治疗结果:8 wk降酶显效率为82%,有效率为90%,对伴持续黄疸3 mo以上者其退黄显效率为96%。治疗后6mo的复发率为29%。此药降酶作用稳定,降酶迅速,无毒副作用,为目前治疗慢性肝炎难得的中药制剂。

By using immunohistochemistry technique, localization of HBsAg and HBcAg was investigated in 21 cases of liver cirrhosis and 18 cases of primary hepatocarcinoma. In liver cirrhosis group, 85.7% showed presence of HBAg. These indicate that there is a close relationship between HBAg and liver cirrhosis. In hepatocellular carcinoma group, 11 cases were accompanied with liver cirrhosis and/or hepatitis which showed presence of HBAg, Positive rate of HBsAg was 41.2%, and HBcAg was 11.8%. These results indicate that...

By using immunohistochemistry technique, localization of HBsAg and HBcAg was investigated in 21 cases of liver cirrhosis and 18 cases of primary hepatocarcinoma. In liver cirrhosis group, 85.7% showed presence of HBAg. These indicate that there is a close relationship between HBAg and liver cirrhosis. In hepatocellular carcinoma group, 11 cases were accompanied with liver cirrhosis and/or hepatitis which showed presence of HBAg, Positive rate of HBsAg was 41.2%, and HBcAg was 11.8%. These results indicate that the onset of hepatocellular carcinoma is closely related with type B hepatitis and liver cirrhosis.

本文应用免疫组化技术对本地区21例肝硬化和18例肝癌进行HBsAg和HBcAg标记定位的比较观察。结果显示,肝硬化组织中HBAg总阳性率为85.7%,说明HBAg与肝硬化有密切关系。肝癌组中,11例伴有HBAg阳性的肝硬化和(或)乙型肝炎。癌细胞内HBsAg阳性率为41.2%,HBcAg阳性率为11.8%,提示本地区肝癌发生与乙型肝炎、肝硬化有密切关系。

The level of prealbumin (PA) decreased markedly but the c response protein (CRP) rose notably in patients with various types of hepatitis and liver cirrhosis, especially in CAH liver cirrhosis and subacute hepatic-necrosis. Trie observation in acutehepalitis (AH)showed that the abnormal levels of PA and CRP persisted in 2 weeks and became normal when patients recovered. The variations of PA and CRP was consistency with the degree of injury in the liver. They were useful for the judgement...

The level of prealbumin (PA) decreased markedly but the c response protein (CRP) rose notably in patients with various types of hepatitis and liver cirrhosis, especially in CAH liver cirrhosis and subacute hepatic-necrosis. Trie observation in acutehepalitis (AH)showed that the abnormal levels of PA and CRP persisted in 2 weeks and became normal when patients recovered. The variations of PA and CRP was consistency with the degree of injury in the liver. They were useful for the judgement of the disease condition and prognosis. The level of a1-AT decreased in patients with AH. CAH and cirrhosis and rose in subacute hepaticnecrosis. a1-AG declined in the majority of the patients with hepatitis, a1-AT and a1-AG rose either when patients recovered from AH, but was not normal either. The combined determination of a1-AT and a1-AG may not only increase the positive rate of liver cancer, but also can monitor the progress of the tumor dasing treatment. The level of CP fell notably in subacute hepaticnecrosis, cirrhosis and CAH and did not change in AH. The clinical significence of the determination on CP still waits to be investigated.

各型肝炎和肝硬化病人PA明显降低,CRP显著升高,均以慢活肝、肝硬化、重肝为甚。急肝动态观察,上述指标两周开始恢复,康复出院时恢复正常,其变化与肝脏损伤程度相一致,因而可用于病情的判断及预后的估计。a_(1)—AT在急肝、慢活肝、肝硬化下降,重肝升高,a_1—AG多数肝病下降,急肝康复出院时两者虽有上升,但并未复常。合并检测这些指标可提高肝癌的阳性率,并可用于监护肝癌治疗的进展。CP在重肝、肝硬化、慢活肝显著降低,急肝各期变化不大,其临床意义有待探讨。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关hepatitis and liver cirrhosis的内容
在知识搜索中查有关hepatitis and liver cirrhosis的内容
在数字搜索中查有关hepatitis and liver cirrhosis的内容
在概念知识元中查有关hepatitis and liver cirrhosis的内容
在学术趋势中查有关hepatitis and liver cirrhosis的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社